Amarantus Bio Raises $5M

Amarantus BioScience Holdings today said that it closed on a $5 million investment from privately held mutual fund Discover Growth Fund. Amarantus plans to use the financing to further develop and commercialize its neurology diagnostic products and therapeutic drug candidates, and for other working capital expenses, it said. In conjunction with the investment, the San Francisco-based company issued a new […]

Read more

Nerd Stalker gets the QB3 pitch

Nerd Stalker gets the QB3 pitch Greg Viloria of the Silicon Valley blog Nerd Stalker interviewed Kaspar Mossman, QB3 communications and marketing director, recently at QB3@953. Greg generously allowed Kaspar to explain the entire spectrum of how QB3 helps Bay Area entrepreneurs start life science companies–Startup in a Box, incubators, the venture fund Mission Bay Capital. Plus, a little about […]

Read more

Helen Lam converts Alector internship into research associate position

Helen Lam converts Alector internship into research associate position During her internship at biotech startup Alector, Helen Lam learned for the first time the advantages that scientists gain by working in a team. She also got a career boost. Helen now works full-time as a research associate at Alector, which develops antibody therapies for Alzheimer’s and other forms of dementia. […]

Read more

Ethan Perlstein featured in Science Careers

Ethan Perlstein featured in Science Careers Ethan Perlstein never planned to be a CEO. Ever since his college research internship in a lab at the National Institutes of Health (NIH), he had dreamed of becoming a professor at a high-powered research institution. After completing his Ph.D. in molecular and cellular biology at Harvard and earning a Lewis-Sigler fellowship at Princeton, […]

Read more

Privail Wins the Vator Splash Health 2015 People’s Choice Award

At Vator Splash Health, Privail won the People’s Choice Award. Here’s the video of Anwaar Al-Zireeni, Privail co-founder and CEO, giving on of the winning presentation. Privail is developing point-of-care diagnostics for the early detection of infectious diseases, with an initial focus on HIV. Unlike current diagnostic methods, Privail’s test detects the virus itself and is available in a simple, […]

Read more

Encoded Genomics, Xcell Bio among those to benefit from Illumina Accelerator’s $40M

Illumina today announced that its startup accelerator has secured $40 million from Viking Global Investors to fund promising genomic firms. Accelerator graduates that raise between $1 million and $5 million in new capital will receive additional dollar-for-dollar match funding from Illumina Accelerator Boost Capital. Read more at GenomeWeb

Read more

Neopeutics Wins 2015 North America Frost & Sullivan Award for Technology Leadership

Based on its recent analysis of the enhanced drug discovery market, Frost & Sullivan recognizes Neopeutics, Inc. with the 2015 North America Frost & Sullivan Award for Technology Leadership. Neopeutics has demonstrated a remarkable ability to innovate by offering clients a robust, cost-effective, and easily adaptable set of drug discovery instruments. It uniquely focuses on agents that are catalogued as […]

Read more

Symic Adds Expertise to its Board

Symic Biomedical announced today the appointment of Barbara Yanni and William J. Newell to its board of directors. Mr. Newell is the CEO of Sutro Biopharma, Inc. which has entered into a strategic collaboration and acquisition option with Celgene regarding their therapeutic technology platform. Ms. Yanni retired in 2014 from Merck & Co., Inc. where she was most recently Vice […]

Read more

Amarantus to Present Positive Alzheimer’s Disease Biomarker Data

Amarantus announced that its abstract titled “The LymPro® Assay: A Biomarker For Alzheimer’s Disease Using Blood Samples From Clinically Diagnosed Alzheimer’s Disease And Cognitively Intact Subjects” was accepted for poster presentation at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PDTM 2015) being held March 18-22, 2015, in Nice, France.  Read the press release at […]

Read more

MedGenome to Raise $15M in Second Round of Funding

MedGenome, backed by Mu Sigma co-founders Dhiraj Rajaram and Ambiga Dhiraj, is looking to raise $15 million in a second round of funding to set up additional genome test labs. The clinical research and diagnostics firm is seeking a valuation of more than $100 million, a near ten-fold jump from last year, when it raised $4 million in its first […]

Read more
Page 7 of 8« First...45678

Upcoming Event

  • Reaction before action: new approaches to biomineralization-associated diseases

    Daniel Laser, PhD CEO and Co-Founder, Applaud Medical RSVP Applaud Medical is a three-year-old company developing treatments for biomineralization-related diseases. Applaud's products use violent physical effects like cavitation and shock waves to achieve a therapeutic effect, while sparing non-targeted tissue through precise chemical targeting. Applaud's lead product, for low-invasiveness treatment of kidney stones, is currently in clinical trials in Gujarat, India. This seminar will cover technical aspects of combining chemical reactions with mechanical action in both Applaud's products and in a range of other drugs and devices, along with a brief discussion of key commercialization considerations for this uniquely promising product category. About Daniel Laser Daniel Laser is Chief Executive Officer and co-founder of Applaud Medical. Dan also founded Wave 80 Biosciences, a pioneer in detecting HIV during the high-transmission-risk earliest phase of infection, when the immune response is insufficiently advanced for antibody-based methods. He has served as board member or advisor to drug and device companies in fields ranging from autoimmune disease to ophthalmology to cancer. Dan got his start in the medical device field working on haptic feedback for telerobotic surgery systems. Dan holds a Ph.D. in mechanical engineering from Stanford University, where he was a Semiconductor Research Corporation Graduate Fellow. While at Stanford, he was also a MacArthur Affiliate at Stanford’s Center for International Security and Cooperation, developing mathematical models for protecting against threats involving weaponized pathogens.


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter